CIK 0001374690
- Non-accelerated filer
- Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203857670
- Phone
- +1 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 76,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 205,000 shares (grant or award)
- 4 Open-market buy Director bought 11,111,108 shares at $3.15 ($34,999,990)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 317,460 shares at $3.15 ($999,999)
- 4 Open-market buy Chief Financial Officer bought 31,746 shares at $3.15 ($100,000)
- 4 Open-market buy President and CEO bought 31,746 shares at $3.15 ($100,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 14 · 272 filings